Drug Screening Market Overview
Drug screening tests utilize biological samples such as saliva, blood and hair to detect the presence of drugs or drugs’ metabolites in a person at a certain point of time. The rapid advancements in science and technology is resulting in the invention various new kinds of drug screening tests that provide better accuracy.
The increasingly prevalent incidences of drug abuse and drug addiction are the main reason behind the high growth rate forecast for the market. Interference of substance abuse and alcoholism with workplaces also leads to the necessity of having enough drug screening tests to ensure maximum productivity at workplaces, which acts as a chief factor behind the market growth.
Drug Screening Market Forecast Report (2018-2023)
Drug Screening Market size approximated at USD 5.9 billion in 2018. It is expected to grow at a CAGR of 9.8% to approach USD 9.42 billion by 2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/drug-screening-market-8110/
Drug Screening Market Segmentation
Drug Screening Market is segmented by Sample Type, End-user and by Products and Services. Under the Sample Type, the market is categorized into Hair, Blood, Urine and Other samples like sweat, saliva. The Urine sample segment led the market in 2016. By End-user, the market is classified into Hospitals, Workplaces and Criminal Justice & Law Enforcement. The workplace segment is expected to grow at a high growth rate, owing to the increasing number of mandatory drug screening tests in the recruitment process of many companies. Under Products and Services, the market is divided into Breathalyser, Rapid Test Device, Immunoassay Analyser, Chromatography and other products. In this segmentation, the Breathalyser segment is predicted to be the top contributor to the global market share.
By region, the global market is examined as North America, Latin America, Europe, Asia Pacific and Middle East and Africa regions. Geographically, North America provided the largest market for Drug Screening in 2016, because of the extremely stringent regulations enforced by regulatory agents like the Drug Enforcement Agency (DEA) of the United States in the region. Asia-Pacific region portrays a high growth rate for the recent future.
The major companies dominating this market for its products and services are
- Thermo Fisher Scientific Inc.
- Express Diagnostics Int’l Inc.
- Abbott Laboratories
- Siemens AG
- Alere Inc.
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Biorad Laboratories Inc.
- Omega Laboratories.
Key Developments in the Market
- November 1, 2018 – DISA has acquired Advanced Workplace Strategies, Inc. (AWSI), an industry-leading employee and applicant screening company.
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Sales Manager at Market Data Forecast
Company Name: Market Data Forecast
Contact Person: Abhishek Shukla
Email: Send Email
Address:Market Data Forecast, Inc. 2 nd floor icici bank